MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 441 to 460 of 5,858 approvalsPage 23 of 293

LYRIJUB CAPSULE 150MG

Approval Number: SIN16798P
Approval: May 30, 2023
GOLDPLUS UNIVERSAL PTE LTD

LYRIJUB CAPSULE 25MG

Approval Number: SIN16800P
Approval: May 30, 2023
GOLDPLUS UNIVERSAL PTE LTD

CIALJUB FILM COATED TABLET 20MG

Approval Number: SIN16796P
Approval: May 26, 2023
GOLDPLUS UNIVERSAL PTE LTD

BEAGABALIN CAPSULE 75MG

Approval Number: SIN16795P
Approval: May 24, 2023
BEACONS PHARMACEUTICALS PTE. LTD.

BEAGABALIN CAPSULE 150MG

Approval Number: SIN16794P
Approval: May 24, 2023
BEACONS PHARMACEUTICALS PTE. LTD.

TECAVIR FILM COATED TABLETS 1 MG

Approval Number: SIN16793P
Approval: May 23, 2023
HETERO SINGAPORE PTE. LTD.

TECAVIR FILM COATED TABLETS 0.5 MG

Approval Number: SIN16792P
Approval: May 23, 2023
HETERO SINGAPORE PTE. LTD.

LEVERA 500 FILM COATED TABLET 500 MG

Approval Number: SIN16790P
Approval: May 22, 2023
ACCORD HEALTHCARE PRIVATE LIMITED

LEVERA 250 FILM COATED TABLET 250 MG

Approval Number: SIN16789P
Approval: May 22, 2023
ACCORD HEALTHCARE PRIVATE LIMITED

ZEPOSIA CAPSULES 0.92 MG

Approval Number: SIN16786P
Approval: May 17, 2023
BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

INTAGRA 100 FILM COATED TABLET 100 MG

Approval Number: SIN16779P
Approval: May 12, 2023
ACCORD HEALTHCARE PRIVATE LIMITED

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.